These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1251855)

  • 1. Incidence of cervical cancer in perimenopausal and postmenopausal women detected by Papanicolaou smears.
    Neighbor RM; Newman RL
    Am J Obstet Gynecol; 1976 Feb; 124(4):348-51. PubMed ID: 1251855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papanicolaou smear screening and cervical cancer. What can you expect?
    Stenkvist B; Bergström R; Eklund G; Fox CH
    JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents with abnormal cervical cytology.
    Schydlower M; Greeenberg H; Patterson PH
    Clin Pediatr (Phila); 1981 Nov; 20(11):723-6. PubMed ID: 7297012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Results of data analysis of mass Papanicolaou screening of 796,337 women in the United States in 1981.
    Sadeghi SB; Hsieh EW; Gunn SW
    Am J Obstet Gynecol; 1984 Mar; 148(6):726-9. PubMed ID: 6702940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teenage cervical carcinoma in situ.
    Wallace DL; Slankard JE
    Obstet Gynecol; 1973 May; 41(5):697-700. PubMed ID: 4696983
    [No Abstract]   [Full Text] [Related]  

  • 6. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
    van Oortmarssen GJ; Habbema JD
    Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplasia and carcinoma in situ of the uterine cervix: prevalence in very young women (under age 22). A one-year study in a health plan population.
    Snyder RN; Ortiz Y; Willie S; Cove JK
    Am J Obstet Gynecol; 1976 Apr; 124(7):751-6. PubMed ID: 1258935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papanicolaou smears in Victoria: are the wrong women being screened?
    Mitchell H; Drake M; Medley G
    Med J Aust; 1987 Dec 7-21; 147(11-12):559-60. PubMed ID: 3696044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecological care of elderly women. Another look at Papanicolaou smear testing.
    Mandelblatt J; Gopaul I; Wistreich M
    JAMA; 1986 Jul; 256(3):367-71. PubMed ID: 3723723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.
    Han MA; Choi KS; Lee HY; Jun JK; Jung KW; Kang S; Park EC
    PLoS One; 2012; 7(4):e35469. PubMed ID: 22530028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delay times to definitive diagnosis after an abnormal Pap smear.
    Mitchell H; Medley G
    Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):283-6. PubMed ID: 3453664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scheduling Pap smears for asymptomatic women.
    Gohagan JK; Swift JG
    Prev Med; 1981 Nov; 10(6):741-53. PubMed ID: 6276879
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with 40,000 Papanicolaou smears.
    Sandmire HF; Austin SD; Bechtel RC
    Obstet Gynecol; 1976 Jul; 48(1):56-60. PubMed ID: 934574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The occurrence of cervix uteri cancer in young women].
    Crane-Elders AB; Bouma J
    Ned Tijdschr Geneeskd; 1982 Nov; 126(46):2096-9. PubMed ID: 7177215
    [No Abstract]   [Full Text] [Related]  

  • 15. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
    Pairwuti S
    Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pap smears: interpreting the new Bethesda terminology.
    Gore H; Shingleton HM
    J Surg Oncol; 1997 Feb; 64(2):95-7. PubMed ID: 9047243
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Screening for cervical cancer.
    Lancet; 1974 Jun; 1(7868):1221. PubMed ID: 4134347
    [No Abstract]   [Full Text] [Related]  

  • 19. Revisiting the effect of the Pap test on cervical cancer.
    Holmquist ND
    Am J Public Health; 2000 Apr; 90(4):620-3. PubMed ID: 10754980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Cervical Cancer Among Low-Risk Populations: Orthodox Jewish Women as a Model.
    Caspi R; Schejter E; Groutz A
    J Womens Health (Larchmt); 2016 Jul; 25(7):747-51. PubMed ID: 26599257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.